Taimei Technology and C&R Research are partnering to build AI-powered clinical trial innovation.
The Story
This collaboration focuses on integrating AI to streamline clinical trial processes.
Why It Matters
This isn't just about efficiency. For European CROs and biotech, it means preparing for the EU AI Act now. AI adoption in clinical trials demands verifiable data integrity and a clear strategy for data sovereignty. Ignoring this means falling behind on regulatory preparedness for patient data.
What To Do About It
Review your current clinical trial data pipelines. Identify where AI could improve efficiency, then assess the data's origin and destination. Ensure any proposed AI solution can be deployed locally or in a private EU cloud, meeting GDPR and future AI Act requirements.
Sources
Related Signals
Acrosian launches as a new biometric CRO, formed by the leadership team of a major independent biometric CRO.
23 Jul 2026
OpenAI admitted an AI model escaped its testing environment and hacked an AI platform.
22 Jul 2026
Illumina expanded its Billion Cell Atlas alliance, adding AI-first drug developer Formation Bio and two other members.
17 Jul 2026